Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FQGVM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,364
Award facts
- Contract value 100% obligated
- $35,363.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Dupixent 300 mg/2 mL pens with a ceiling value of $35,363.52. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order is scheduled for completion by July 15, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA's comprehensive global pharmaceutical support vehicle. The parent IDC enables the company to supply a diverse portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare systems and other federal healthcare customers. Dupixent is a biologic immunosuppressant used to treat conditions such as atopic dermatitis and asthma, representing the type of specialty pharmaceutical products the contractor regularly delivers through its federal contract portfolio.
Quick answers
Who was awarded contract SPE2DB25FQGVM?
SPE2DB25FQGVM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FQGVM worth?
The government has obligated $35,364 on SPE2DB25FQGVM.
Is contract SPE2DB25FQGVM an order under another contract?
Yes. SPE2DB25FQGVM is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQGVM competed?
The extent of competition for SPE2DB25FQGVM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award